awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36174832-359F9ACE-FCAA-4843-B2DF-1B897791F66A
Q36174832-359F9ACE-FCAA-4843-B2DF-1B897791F66A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36174832-359F9ACE-FCAA-4843-B2DF-1B897791F66A
Next-Generation Sequencing to Guide Clinical Trials.
P2860
Q36174832-359F9ACE-FCAA-4843-B2DF-1B897791F66A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36174832-359F9ACE-FCAA-4843-B2DF-1B897791F66A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
728f662ea8052e669913f84db31d99ba7a52db9a
P2860
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.